Aarti Pharmalabs Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹990.70
-33.90-3.31% (1D)
As on 20 Nov 2026 at 15:58
As of 20 Nov 2026 at 15:58, Aarti Pharmalabs Ltd is trading at ₹990.70. The 52-week range stands at ₹585.00–₹1,047.25, with a market cap of ₹8.98 thousand crore. At a P/E of 36.40 and a dividend yield of 0.35%, it is a mid-cap stock in the Pharmaceuticals sector.

AARTIPHARM Price Chart

Market Cap
₹8.98K Cr
PE Ratio
36.40
ROCE
12.64%

Aarti Pharmalabs Ltd Performance

Aarti Pharmalabs Ltd Fundamentals

Know More
Market Cap₹8.98K Cr
ROE11.55%
P/E Ratio (TTM)36.40
EPS (TTM)₹27.19
P/B Ratio4.27
Dividend Yield0.35%
Industry P/E91.72
Book Value₹231.94
Debt to Equity0.43
Face Value₹5

Aarti Pharmalabs Ltd Shareholding Pattern

Know More
Promoter39.7%
Foreign Institutions8.2%
Mutual Funds0.6%
Domestic Institutions7.8%
Public43.8%

Aarti Pharmalabs Ltd Financial Statements

Know More
No data for this view.

Aarti Pharmalabs Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Aarti Pharmalabs

Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019. The name of the Company was changed to Aarti Pharmachem Limited in July, 2021 and again to Aarti Pharmalabs Limited in 2022. The Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), CDMO services and Xanthine derivatives situated in India. It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022. In 2021-22, the Pharmaceutical Division was demerged from Aarti Industries Limited into its wholly owned subsidiary, Aarti Pharmalabs Limited, via Scheme of Arrangement for Demerger, thus making it effective on October 17, 2022 and operational from July 1, 2021. Thereafter, Company commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023. The R&D centre in Nerul, Navi Mumbai became fully operational in FY 2024. The Company commenced operations for its semi-commercial block at the USFDA intermediate manufacturing site in Vapi in FY24. The Xanthine capacity enhanced to 5000 TPA in 2024 and to 9,000 MTPA in 2025. Atali greenfield facility Phase I commissioned operations in 2025-26.

Parent Organisation—
Founded2019
Managing DirectorHetal Gogri Gala
NSE SymbolAARTIPHARM

Aarti Pharmalabs Ltd Resistance and Support levels

R31,056.37R21,040.93R11,031.40S11,000.53S2991.00S3975.57990.70

Aarti Pharmalabs Ltd Technicals

Current Price
₹990.70 ₹33.90 (-3.31%)
Bearish
2
Bullish
10
  • 20 Day4.3%
  • 50 Day9.8%
  • 100 Day16.4%
  • 200 Day23.2%

Aarti Pharmalabs Ltd Latest News

View More
16 NOV 2026 | Monday
Aarti Pharmalabs announces the passing of Chairman Emeritus Shri Chandrakant Gogri
09 OCT 2026 | Friday
Aarti Pharmalabs to review financial results at a board meeting on October 28, 2026
09 OCT 2026 | Friday
Aarti Pharmalabs receives certificate from MUFG Intime India for quarter ending September 2026
28 SEPT 2026 | Monday
Aarti Pharmalabs will halt securities trading from October 1, 2026, per SEBI regulations
31 AUG 2026 | Monday
Aarti Pharma Labs announced the resignation of G.M. Naidu, effective August 31, 2026
17 AUG 2026 | Monday
Aarti Pharmalabs sets record date for final dividend payment of Rs 2.00 per share
10 AUG 2026 | Monday
Aarti Pharmalabs Ltd leads gainers in 'A' group
07 AUG 2026 | Friday
Aarti Pharmalabs director Rajendra Gogri will retire at the upcoming AGM
28 JUL 2026 | Tuesday
Aarti Pharmalabs announces board meeting date
25 JUN 2026 | Thursday
Aarti Pharmalabs allots 22,062 equity shares under ESOP

2026

Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Aarti Pharmalabs Ltd is ₹990.70 as of 20 Nov 2026 at 15:58.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now